NCT02359227View on ClinicalTrials.gov

Safety Study of Cenderitide in Stable Chronic Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 2, 2015

Study Completion Date

April 2, 2015

Conditions
Heart Failure
Interventions
DRUG

Cenderitide

Cenderitide is a dual receptor natriuretic peptide.

Trial Locations (1)

92780

Orange County Research Center, Tustin

All Listed Sponsors
lead

Capricor Inc.

INDUSTRY

NCT02359227 - Safety Study of Cenderitide in Stable Chronic Heart Failure | Biotech Hunter | Biotech Hunter